(Q41706239)

7 October 2017

1 reference

title

Adverse effects of amiodarone (English)

1 reference

7 October 2017

1 reference

amiodarone

15 June 2024

Jafari-Fesharaki M

1

1 reference

7 October 2017

Scheinman MM

series ordinal

2

1 reference

7 October 2017

publication date

1 January 1998

1 reference

Pacing and Clinical Electrophysiology

7 October 2017

published in

1 reference

7 October 2017

volume

21

1 reference

7 October 2017

issue

1 Pt 1

1 reference

7 October 2017

page(s)

108-120

1 reference

Side effects from amiodarone

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Side effects and possible contraindications of amiodarone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Low-dose amiodarone for the treatment of arrhythmias in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Long-term efficacy and toxicity of high- and low-dose amiodarone regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Side effects and complications of amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Histopathologic analysis of suspected amiodarone hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Amiodarone photosensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Relationships between amiodarone dosage, drug concentrations, and adverse side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Ocular effects in long-term amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Frequent neurologic toxicity associated with amiodarone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Amiodarone pulmonary toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Effects of amiodarone on thyroid function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Amiodarone induced hyperthyroidism: a case series and brief review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Amiodarone: reevaluation of an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Amiodarone and torsades de pointes in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

The rational use of intravenous amiodarone in the perioperative period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Drug interactions with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

Enhanced Susceptibility to Amiodarone-Induced Hypothyroidism in Patients With Thyroid Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1998.TB01068.X

10.1111/J.1540-8159.1998.TB01068.X

21 January 2018

Identifiers

DOI

1 reference

7 October 2017

1 reference